Decatur, GA, United States of America

Yesim Altas


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yesim Altas: Innovator in Neuroprotective Drug Development

Introduction

Yesim Altas is a prominent inventor based in Decatur, Georgia, known for her significant contributions to the field of neuroprotective drugs. With a focus on developing pH-dependent NMDA receptor antagonists, her work addresses critical neurological conditions that arise from acidification of brain or spinal cord tissue.

Latest Patents

Yesim Altas holds one patent for her innovative work on pH-sensitive NMDA receptor blockers. These neuroprotective drugs are designed to be effective in treating various neurological events, including stroke, traumatic brain injury, and epilepsy. The compounds she has developed show enhanced activity in brain tissue with lower-than-normal pH, which is often a result of pathological conditions such as hypoxia. This invention aims to prevent neurodegeneration in patients suffering from conditions like Parkinson's disease, Alzheimer's disease, and ALS.

Career Highlights

Yesim Altas is affiliated with Emory University, where she continues her research and development in neuropharmacology. Her work has the potential to significantly impact the treatment of neurodegenerative diseases and improve patient outcomes.

Collaborations

Yesim has collaborated with notable colleagues in her field, including Stephen F. Traynelis and Dennis C. Liotta. These partnerships have furthered her research and contributed to the advancement of neuroprotective therapies.

Conclusion

Yesim Altas is a trailblazer in the development of neuroprotective drugs, with her innovative patent addressing critical neurological issues. Her contributions to the field are poised to make a lasting impact on the treatment of neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…